FDA Clearance Tracker · P140004-S002
SUPERION INTERSPINOUS SPACER
Last checked: Nov 20, 2026Latest source record: Dec 15, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Dec 15, 2015
Approved
Time to decision
176 days
Received Jun 22, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P140004-S002
- Device name
- SUPERION INTERSPINOUS SPACER
- Applicant
- Boston Scientific Neuromodulation
- Applicant location
- Valencia, CA
- Received
- Jun 22, 2015
- Decided
- Dec 15, 2015
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P140004
Device type
- Device class
- Class III
- Specialty
- Orthopedic SurgerySpine
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for Boston Scientific Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251247 · Decided Aug 7, 2025 · 106 days after receipt
Device type: Generator, Lesion, Radiofrequency (GXD) · Neurology & Neurosurgery
K233801 · Decided Aug 23, 2024 · 268 days after receipt
Device type: Stimulator, Spinal-Cord, Implanted (Pain Relief) (GZB) · Neurology & Neurosurgery
K232415 · Decided Aug 21, 2024 · 376 days after receipt
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.